ONDS:NASDAQOndas Inc Analysis
Data as of 2026-05-20 - not real-time
$9.36
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Ondas Inc. (NASDAQ:ONDS) has just completed a $175 million merger with Mistral, unlocking direct access to U.S. Army and Special Operations contract vehicles and securing an initial $140 million multi‑year order. The stock trades around $9.36, well above the DCF‑derived fair value of roughly $2, indicating a substantial valuation premium. Technicals are mixed: the 20‑day SMA (≈9.80) sits just below the 50‑day SMA (≈9.88), the RSI hovers near 47, and the MACD histogram is negative, suggesting short‑term bearish momentum, while volume is increasing. Fundamental metrics are weak – a trailing PE of ~104 versus an industry average of ~39, negative operating margins, and a max drawdown of over 53% – yet the company holds a massive cash buffer (~$572 million) and low debt. Analyst sentiment remains highly bullish, with a “strong buy” consensus and an implied upside of over 115% based on current price. The sector (technology‑communication equipment) carries medium regulatory exposure, and the stock’s beta of >3 signals high systematic risk. Investors should weigh the near‑term technical weakness against the strategic growth catalyst of the merger and defense contracts.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Recent $175 M merger unlocking defense contract pipeline
- Bearish MACD and neutral RSI indicating price support levels
- High analyst consensus and strong buy rating
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Significant valuation premium relative to DCF and peers
- Continued negative operating margins and cash flow pressure
- Increasing trading volume suggesting market interest
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term defense contract backlog and potential recurring revenue
- Strong cash position to fund R&D and scale operations
- Strategic positioning in autonomous aerial and ground robotics market
Key Metrics & Analysis
Financial Health
Revenue Growth629.20%
Profit Margin-260.23%
P/E Ratio104.0
ROE-52.56%
ROA-5.44%
Debt/Equity5.34
P/B Ratio8.1
Op. Cash Flow$-38746000
Free Cash Flow$12.0M
Industry P/E38.8
Technical Analysis
TrendNeutral
RSI47.0
Support$8.65
Resistance$12.12
MA 20$9.80
MA 50$9.88
MA 200$8.68
MACDBearish
VolumeIncreasing
Fear & Greed Index90.29
Valuation
Fair Value$1.95
Target Price$20.13
Upside/Downside115.01%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.16
Volatility99.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.